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Background: To assess potential long-term consequences of cancer treatment, studies that include comparison
groups are needed. These comparison groups should be selected in a way that allows the subtle long-range effects
of cancer therapy to be detected and distinguishes them from the effects of aging and other risk factors. The
purpose of this investigation was to test two methods of recruiting a comparison group for 5-year oral and
pharyngeal cancer survivors (peer-nominated and listed sample) with emphasis on feasibility and the quality of the
match.
Methods: Participants were drawn from a pool of 5-year survivors treated at a large Southeastern hospital. A peer-
nominated sample was solicited from the survivors. A listed sample matched on sex, age, and zip code was
purchased. Telephone interviews were conducted by a professional call center.
Results: The following represent our key findings: The quality of matching between survivors and listed sample was
better than that between survivors and peer-nominated group in age and sex. The quality of matching between
the two methods on other key variables did not differ except for education, with the peer method providing a
better match for the survivors than the listed sample. The yield for the listed sample method was greater than for
the peer-nominated method. The cost per completed interview was greater for the peer-nominated method than
the listed sample.
Conclusion: This study not only documents the methodological challenges in selecting a comparison group for
studies examining the late effects of cancer treatment among older individuals but also documents challenges in
matching groups that potentially have disproportionate levels of comorbidities and at-risk health behaviors.Background
Individuals are surviving cancer for longer time periods
[1,2]. However, survivors face treatment protocols that
may produce late effects that negatively affect quality of
life [3-5]. Some effects appear transient and end with treat-
ment [6], but many may persist for months and even years
[3,7-9]; others develop later [10,11]. The greatest collection
of work on long-term treatment effects is related to child-
hood cancers but evidence on adult-onset malignancies is
accumulating (e.g., [3,4,12-18]). Few cancer treatments are
free of risks and most survivors face long-term adverse
consequences of treatment [3]. Despite advances in our
current cancer survivorship research, there are still serious* Correspondence: hlogan@dental.ufl.edu
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reproduction in any medium, provided the orgaps in our knowledge of late effects, especially in under-
studied cancers of older individuals [19].
Investigation of older cancer survivors to identify and
document the prevalence of these late and long-term
effects requires careful attention to the selection of an
appropriate comparison group [20]. For instance, as
people age, medical comorbidities become more com-
mon. Among individuals with high lifetime exposure to
alcohol and tobacco, the proportion developing comor-
bidities, including cardiovascular disease, is believed to
be greater than in the general population [21]. In study-
ing the rate at which late effects from cancer treatment
occur, including conditions such as cardiovascular dis-
eases or secondary tumors, researchers must be careful
that the effect of the cancer treatment is not being con-
founded with the effects of aging or “at-risk” health
behaviors.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
378 5-years survivors alive at last 
contact to which letters were mailed 
with toll-free telephone number* 
100 completed telephone 
surveys
7 refused * 
20 refusals (no reason given) 
Phone list of 365 remaining 
survivors generated
83 no response or repeated requests 
to call back
6 bad addresses 
102 bad telephone numbers (fax 
line, disconnected, non-working) 
4 partial completes 
14 refused because mentally or 
physically ill 
6 deceased 
30 non-eligible respondents  
6 telephone numbers not called 
because target number reached 
Figure 1 Flowchart of survivor recruitment.
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http://www.biomedcentral.com/1471-2288/12/63The study of late effects of treatment among oral and
pharyngeal cancer (OPC) survivors presents challenges
similar to those of other cancers in older individuals
[22]. Many survivors of OPC face disfiguring surgery,
damage to oral function, and increased acute and late
toxicities resulting from more aggressive multimodal
treatment regimens [23]. In addition, these cancers dis-
proportionately affects older ethnoracially diverse men
for whom accurate incidence data on specific negative
health outcomes may not be available [24]; there are also
no normative data for frequently used assessment scales
[25]. In the past, few studies of OPC survivors included
a control group matching the target group on relevant
lifestyle factors, such as tobacco and alcohol use [20].
This limitation in otherwise informative studies makes it
problematic to draw conclusions about the long-term
effects of cancer therapy [25-28].
Several methods to produce comparison data have been
proposed, ranging from community-based to within-subject
designs [29]. One major problem with population-based
comparison groups is that tobacco and alcohol lifetime
exposure may be lower than those of cancer survivors. This
is a particular problem in the case of OPC because tobacco
and alcohol use are putative risk factors and independently
produce negative health outcomes. Therefore, matching on
tobacco use and alcohol use is desirable if the effects of
treatment are to be separated from those associated with
these “at-risk” behaviors [30].
A peer-matched strategy is believed to offer advantages
[31-33]. Compared to the case-survivors, friends may use
the healthcare system in similar ways and may be of
similar socioeconomic background and lifestyle [34].
Tobacco and alcohol use may also be similar. Older sur-
vivors, however, may not be able to nominate a peer,
especially when they have experienced debilitating late
effects and have become socially isolated [35]. Concern
is often raised that using friend-nominated controls may
result in overmatching, a phenomenon in which match-
ing occurs on an intermediate variable in a causal path-
way resulting in bias [36]. When the risk factors for the
disease are age and lifestyle-related and we seek to exam-
ine the consequences of cancer treatment, it may be ne-
cessary to homogenize the group [37,38].
The purpose of this investigation was to compare and
contrast two methods of recruiting a comparison group
for five-year survivors of OPC—a peer-nominated con-
trol group and a listed sample—on quality of the match,
costs, and feasibility. Match was defined as similarity in
sex, race, age, smoking and alcohol use, employment,
and education level [39].
Methods
A professional call center conducted a 20-minute tele-
phone interview with all participants in this project. Theoverall goal of the interview was to assess pain levels of
a matched non-cancer comparison group to 5-year sur-
vivors of head and neck cancer and to test predictive
models of oral pain among 5-year survivors. The survey
and methodology received prior approval from the
Institutional Review Board at the University of Florida.
Items were drawn from published instruments and are
reported elsewhere [40]. Participants received a $25 gift
card for completing the survey.
A target of 100 survivors, 100 friends, and 100 from
the listed sample had been set in advance. Best practices
(to meet the target numbers) were used by the profes-
sional call center to contact participants for each of the
three groups, cancer survivor group, peer-nominated
comparison group, and listed sample comparison group.Selecting survivors
Survivors were drawn from 378 individuals treated for
OPC at the institution’s radiation oncology clinic and who
had survived five years (plus or minus three months). After
verification of status and contact information, the 356
remaining individuals were sent a letter describing the
study. (See Figure 1.) A toll-free number was provided for
those who did not wish to participate in the study, and
seven individuals requested not to be called for the survey.
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conducted the survey.Selecting peer-nominated group
Individuals from the survivor group were contacted first
and were asked to provide the name and telephone num-
ber of two peers who were similar to themselves, who
had not had cancer, and who might participate. Peers
were screened to exclude respondents with a history of
cancer. (See Figure 2)Selecting listed sample methodology
A commercial list was purchased that matched the survi-
vors by age (within five years), sex, and geographical loca-
tion. Ten people of the same sex and age (+/− five years)
were selected from each survivor’s zip code. Numbers
were chosen randomly from that list until one individual91 peers nominated by 61 of 
the 5-years survivors 
44 completed surveys 
31 survivors 
nominated 1 peer 
12 refusals  
15 no response or repeated requests 
to call back
30 survivors 
nominated 2 peers 
6 bad telephone numbers 
(disconnected and non-working) 
14 non-eligible respondents  
Figure 2 Flowchart of peer nominee recruitment.completed the survey. Each participant was screened to
exclude those with a history of cancer. (See Figure 3)Data analysis
Descriptive statistics were calculated as percentages,
means, and standard deviations. To calculate the cost in-
curred, we divided the base cost of $25/hour, which
included both fixed and variable costs for the survey, by
the number of surveys completed per hour for each
group respectively. This base cost may have differed re-
gionally but provided general guidance for cost compari-
son. That amount was multiplied by the number of
completed surveys for each method, giving a measure of
total costs per group.
We evaluated the matching properties of the samples
onsex, race, age, education, employment status, and
cigarette and alcohol use. Alcohol use was derived from
these questions: “How often do you drink?” “How much
do you drink when you drink?” and “How often do you
drink at least six drinks in one day?” Duration of smok-
ing was calculated as the difference between age at the
first cigarette and age at last cigarette. For current smo-
kers, current age was used as age at last cigarette.98 strata (with 10 telephone 
numbers per strata) were matched 
by gender, age, and zip code to the 
5-years survivors. 
101 completed telephone surveys 
117 refusals (no reason given) 
List of 980 telephone numbers 
generated.  Phone calls were made 
in each stratum until a completed 
survey was achieved. 
188 no response or repeated 
requests to call back 
40 bad telephone numbers (fax line, 
disconnected, non-working) 
4 partial completes 
16 refused because mentally or 
physically ill 
18 reported eligible person 
deceased
60 non-eligible respondents  
436 telephone numbers not 
called when completed survey 
achieved in stratum. 
Figure 3 Flowchart of listed sample recruitment.








Men 72% 43% 71%
Women 28% 57% 29%
Race
White 94.0% 96.0% 93.0%
Black 2.0% 2.0% 4.0%
Other 4.0% 2.0% 3.0%
Education
Less than HS 7.0% 6.8% 10.9%
High School grad
or equivalent 21.3% 25.0% 21.8%
Post HS education 71.6% 68.2% 67.4%
Employment Status
Currently employed 32.0% 50.0% 43.0%
Retired 68.0% 47.0% 57.0%
Other - 3.0% -
Disabled 19.0% 4.8% 10.3%
Married 72.0% 77.3% 79.2%
*Prevalence of current smoking 15.0% 27.0% 10.0%
*Proportion who have smoked in the last 30 days.
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http://www.biomedcentral.com/1471-2288/12/63Two analytic strategies were used. First, we tested for
marginal group differences. We then tested for the qual-
ity of the match at an individual pair level.
To test for marginal group differences in each variable,
we used two-sided p-values for testing Ho: “the marginal
distribution of survivors is the same as that of peers” vs.
Ha: “the marginal distributions are different.” Similarly,
we used two-sided p-values for testing Ho: “the marginal
distribution of survivors is the same as that of listed
sample” vs. Ha: “the two marginal distributions are differ-
ent”; the smaller the p-value, the larger the difference be-
tween the two marginal distributions.
To compare the quality of match between the survivor
and the peer to that between the survivor and the listed
sample, we calculated the absolute difference between
each pair on each variable. We used a Wilcoxon rank
sum test to determine whether the two groups of differ-
ences were different. One-sided p-values were reported for
testing Ho: “the quality of matching between peers and
survivors is the same as that between listed sample and
survivors” vs. Ha: “the quality of matching between peers
and survivors is better than that between listed sample
and survivors.” If p-value< 0.05, then we would claim that
the quality of matching between peers and survivors
was better than that between listed sample and survivors;
if p-value> 0.95, then vice versa. If p-value< 0.5, then
there was a trend that the quality of matching between
peers and survivors was better than that between listed
sample and survivors; if p-value> 0.5, then vice versa.
We used the Wilcoxon rank sum test to compare the
locations of two distributions. Because the data con-
tained paired and unpaired observations, the assumption
of independence between observations did not hold. The
method proposed by Hollander and colleagues [41] was
adapted for correlated data. P-values were obtained from
testing the group difference by the permutation method
described in Dallas and Rao [42].
We compared both marginal group differences and ab-
solute differences between pairs in order to provide a
comprehensive picture to evaluate each method. For in-
stance, we expected the match on age and sex to be ex-
cellent for the listed sample and survivors because the
telephone screening specified this match. If the quality of
the match was similar for the peer group and survivors
on these variables, then we could conclude that either
approach was adequate. In contrast, we might expect al-
cohol and tobacco use to be more similar between the
individuals in the peer group and the survivors than be-
tween those matched in the listed sample. The compari-
son of two marginal distributions may, however, be
misleading. For example, the paired data (1,10), (10,1),
(1,10), (10,1) show no difference between the two mar-
ginal distributions (means equal 5.5), but the quality of
match at the individual level is quite poor.Results
Characteristics
Table 1 shows subject characteristics divided by selection
method. Table 2 shows the means and Table 3 shows the
p-values for matching variables (including sex, age, edu-
cation, employment, smoking and alcohol history).Recruitment and retention
Figures 1, 2, and 3 provide flowcharts of the recruitment
patterns for each of the three groups. The interviews
were conducted over a 6-month time period and the
same interviewers were used for each group.
Figure 1 shows the disposition of the recruitment. Eli-
gible survivors were based on those alive at last contact
from the Department of Radiation Oncology and con-
firmed through the Tumor Registry Shands at University
of Florida. In response to the letter that was mailed,
seven survivors called the toll-free number requesting
not to be called. After multiple attempts to obtain a cor-
rected phone number, six names had to be dropped from
the list. When the calls were made by the professional
call center, 20 individuals refused to participate and 83
either repeatedly requested we call back or the call was
never answered. Six survivors had died and 14 were ei-
ther too mentally or physically compromised to partici-
pate in the survey. Four partially completed the survey
but were never available to finish the questionnaire. All
Table 2 Means for matching variables
Sample Size* Mean (S.D.)
Group Survivor Peer Listed Survivor Peer Listed
Variable
Age (yrs)** 100 44 96 64.90 (10.09) 57.40 (13.9) 64.4 (10.08)
Days of Smoking in the past 30 100 44 96 4.25 (10.3) 6.29 (11.7) 2.54 (8.13)
Lifetime duration of smoking 60 27 53 36.60 (15.0) 30.40(14.2) 28.90 (15.1)
How often do you drink alcohol?
(during month)
100 44 95 1.50 (1.63) 1.50 (1.30) 1.64 (1.64)
How much alcohol do you drink on
a typical day when you are drinking?
(number of drinks)
99 42 95 0.66 (0.70) 0.98 (0.87) 0.77 (0.74)
How often do you drink six drinks of
alcohol in one day? (during month)
100 34 95 0.78 (0.95) 1.03 (1.31) 0.82 (0.82)
*: Sample sizes vary due to missing data.
**: Median ages (range) in survivor group, peer group, and listed group were 65.5 (33-90), 59.5 (29-80), and 64.0 (32-90), respectively.
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year survivors were used to complete the 100 surveys
(100/372 = 27%).
Figure 2 shows data regarding recruitment of the peer-
nominated group. Of the 100 survivors who completed
the questionnaires, 61 recommended at least one peer:
thirty-one survivors provided one peer and 30 survivors
nominated two peers, yielding a total of 91 nominees.
Because we had fallen short of our target of 100 peer
nominees, multiple attempts were made to contact all of
the nominees; 12 refused and six telephone numbers
were non-working. Fourteen nominees reported that
they were not eligible, either because they had a history




Sex of subject! 100 44
Age (yrs)!! 100 44
Education! 99 44
Employment! 100 44
Days of smoking in the past 30 100 44
Lifetime duration of smoking 60 27
How often do you drink alcohol?
(during month)
100 44
How much alcohol do you drink
on a typical day when you are
drinking? (number of drinks)
99 42
How often do you drink six drinks
of alcohol in one day? (during month)
100 34
*: sample sizes vary due to missing data.
#: Two-sided p-values for testing Ho: “the marginal distribution of survivors is the sa
smaller the p-value, the larger the difference between the two marginal distribution
$: Two-sided p-values for testing Ho: “the marginal distribution of survivors is the sa
different.” The smaller the p-value, the larger the difference between the two margi
^^: One-sided p-values for testing Ho: “the quality of matching between peers and
quality of matching between peers and survivors is better than that between listedthe figure, additional analysis showed that the percentage
of men and women survivors who nominated a peer
were roughly the same. Seventy-two percent of the men
were able to nominate at least one peer, as did 79% of
the women survivors. Of those peers nominated, we
were able to contact 38% of the men nominees compared
to 64% of the women. The observed success rate for con-
tacting the peer-nominated group was 44/91 = 48.3%.
The yield for the listed sample as shown in Figure 3
was 101/544 = 19%. Out of the original 980 telephone
numbers purchased, all but 436 were used to complete
the sample. One hundred seventeen refused with no rea-
son given, and another 188 either repeatedly asked the







96 0.47 1.00 0.99
96 0.017 0.79 1.00
96 0.75 0.41 0.018
96 0.18 0.25 0.28
96 0.07 0.23 0.77
53 0.32 0.011 0.18
95 0.77 0.44 0.23
95 0.40 0.26 0.53
95 0.51 0.42 0.25
me as that of peers” vs. Ha: “the two marginal distributions are different.” The
s.
me as that of listed sample” vs. Ha: “the two marginal distributions are
nal distributions.
survivors is the same as that between listed samples and survivors” vs. Ha: “the
samples and survivors.”
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sample of women required 4.6 of 10 numbers to be used;
men required 5.9. The average of telephone numbers
from the strata used to reach the group under 65 years
was 5.6 and for those 65 years or older was 5.5.
Cost of completed calls
The maximum number of telephone call attempts for
the survivor, peer nominee, and listed sample individual
were 11, 19, and 15, respectively. The rate of completed
calls per hour ranged from a high of .65 for the survivors
to a rate of .40 for the peer-nominated group (See
Table 4). For each completed call in the survivor group,
the cost, which included the $25/hour charged by the
call center, was $38.46, compared to $41.66 for the listed
sample and $62.50 for the peer-nominated sample.
Matching
Table 2 shows the means, standard deviations, and
Table 3 shows the p-values for the comparison between
the survivor group versus the peer-nominated and listed
sample groups, respectively. Column five in Table 3,
titled Survivor vs. Peer, shows the two-sided p-values for
testing whether the marginal distribution of the variable
in column 1 for survivors is the same as or different than
that for the peer-nominated sample. Column six in
Table 3, titled Survivor vs. Listed, shows the two-sided
p-value for testing whether the marginal distribution of
the variable in column 1 for survivors is the same as or
different than that for the listed sample. For both columns
five and six, the smaller the given p-value, the larger the
difference is between the two marginal distributions. The
final column in Table 3 shows the one-sided p-value for
the test of the overall quality of match. The p-values were
obtained by testing the null hypothesis, “the quality of
matching between peers and survivors is the same as that
between listed samples and survivors” vs. the alternative
hypothesis, “the quality of matching between peers and
survivors is better than that between listed samples and
survivors.”
The peers smoked more in the 30 days prior to the
survey (average smoking days 6.29) compared to both the
survivors and the listed sample. The difference in past 30-
day smoking between survivors and the peer group yielded





Total costs per group $3884.46
Completes per hour 0.65
Costs per completed
telephone interview
$25/0.65 = $38.46for the survivors and the listed sample was .23. Table 3
shows, however, that the quality of the match at the indi-
vidual pair level did not differ on days of smoking in the
past 30 days (p=0.77). That is, we could not reject the null
hypothesis. In terms of lifetime duration of smoking, there
was a trend toward the peer-nominated group yielding a
better match with the survivors than the listed sample
(p=0.18). The survivors had significantly greater duration
on smoking than the listed sample (36.60 vs. 28.90,
p =0.011), whereas survivors and peers (36.60 vs. 30.40,
p =0.32) were more similar. No differences approached
significance for alcohol use.
Overall, we observed that the quality of the matching
was not significantly different between the two methods
except on age, sex, and education level. Specifically, at the
individual pair level, the listed sample produced a better
match on age and sex than the peer-nominated group
(p=0.99 and 1.00, respectively). Age (64.90 vs. 64.40)
(Table 2) and sex distribution (72% men vs. 71% men)
(Table 2) were nearly identical for the survivors and listed
sample, respectively. The peer-nominated group produced
a better match on education than the listed sample (e.g.,
6.8% less than high school for peers vs. 7.0% less than high
school for survivors) (Table 1). Thus, as we show in
Table 3, we reject the null hypothesis (p= 0.018).Conclusions
The key findings from this study are (1) The quality of
matching between the two methods of choosing a com-
parison group for five-year cancer survivors did not dif-
fer except for education; the peer method provided a
significantly better match for the survivors than the
listed sample, and the listed sample, as expected, pro-
duced a match on age and sex based on the criteria used
to purchase the list; (2) The yield for the listed sample
method was greater than for the peer-matching method;
(3) The cost per completed interview was greater for the
peer-matching method than the listed sample. Previous
studies have documented important changes in patients’
ability to function following cancer treatment but the
goal of survivorship research has expanded to include
understanding the more subtle effects of treatment [25].
To accomplish this goal, longer term studies with appro-




$2750.00 $4207.66 (includes purchase of
telephone list in hourly rate)
0.40 0.60
$25/0.40 = $62.50 $25/0.60 = $41.66
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comparison group yield similar matches to the survivor
group with the exception of education level. The out-
come of our study is somewhat different from that
reported by Kaplan et al. [35]. They found that peer
nominees were better educated than the target group
and hospital patients from the same catchment area. We
found that the peer group was less educated. This is an
issue that may affect some survivor studies, especially
where socioeconomic status is a consideration. We
found a trend toward a better match on lifetime duration
of smoking for the peer-nominated and survivor groups
that may interest some investigators. Smoking exposure
is known to carry its own health risks, and when the
cancer survivors and controls are not matched on this
variable, it may be problematic to separate the effects of
cancer treatment from those of smoking exposure.
Kaplan found [35] that older patients were less likely
to nominate a peer for the comparison group than
younger patients. Our challenge was not in the nomin-
ation of a peer but in our ability to contact that nominee,
which affected the yield of participants and the cost per
completion of the survey. Reducing the delay by telephon-
ing the peers immediately after their number is obtained
might reduce the amount of nonworking numbers. A sec-
ond alternative could be to mail a letter to the nominee
asking them to verify their telephone number. These
methods would allow immediate corrective actions to any
bias in men and women survivors having correct contact
information. Our success with the toll-free number for the
survivors to call for information suggests that we should
offer one to nominees in the future. In short, refining the
methodology may provide a closer match on sex for the
peer-nominated and survivor group while also lowering
the cost per completion. Overall, 91 peers were nomi-
nated, but after 19 attempts, we were only able to reach 44
peers. Of those 44 peer respondents, we noted that 19 of
the women peers were nominated by women survivors,
while 6 were nominated by men survivors. Our instruc-
tions to the survivors did not specify that the nominees be
the same sex. Visual inspection of the data suggests that
the telephone numbers of the male nominees were less ac-
curate or less likely to be answered after multiple attempts
than for the women nominees. This added to the cost per
completion and may have contributed to the poorer match
on sex.
The results of the test for match quality showed the
two methods yielded similar results. This must be con-
sidered in light of the greater cost per successful comple-
tion for the peer-nominated method and its low yield in
this study. We maintain that our experience is important
for any researcher hoping to investigate the late effects
of cancer or cancer treatment among older adults [25].
We found that the survivors nominated peers, but thechallenge was in contacting those nominees. Readers
should be aware that the listed sample was purchased for
$715, and this was a part of the variable cost figured into
the survey center’s hourly rate. Mailings to the initial 378
survivors added to our recruitment costs, but are not
included in the survey center’s hourly rate.
In summary, we tested the methods using both a test of
the marginal distributions by group and the differences at
the individual pairs in an attempt to provide methodo-
logical evidence for comparison group selection. Our
results indicate that investigators of the late effects of
cancer treatment should give careful consideration to the
methods for comparison group selection. We believe that
many of the lessons learned from this study generalize to
comparison group selection for the study of other adult-
cancer survivors.
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